Patricia Bernardo

Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)

George W. Sledge, Donna Neuberg, Patricia Bernardo et al. · Journal of Clinical Oncology · 2003 · 707 citations

Medicine, Oncology, Pharmacology +15

Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After First-Line Chemotherapy: Eastern Cooperative Oncology Group Trial E2196

Joseph A. Sparano, Patricia Bernardo, Patricia Stephenson et al. · Journal of Clinical Oncology · 2004 · 268 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired Pneumonia

Peter Pertel, Patricia Bernardo, Charles Fogarty et al. · Clinical Infectious Diseases · 2008 · 161 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After <i>Clostridioides difficile</i> Infection: Lessons Learned From a Phase 2 Trial

Barbara McGovern, Christopher B. Ford, Matthew R. Henn et al. · Clinical Infectious Diseases · 2020 · 158 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

Matthew R. Henn, Edward J. O’Brien, Liyang Diao et al. · Gastroenterology · 2020 · 109 citations · Full text

Life Sciences, Immunology, Microbiology +17